Lexaria Bioscience Corp. - *W EXP 01/14/202 (LEXXW)

CUSIP: 52886N117

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / *W EXP 01/14/202
Total 13F shares
85,026
Share change
-1,771
Total reported value
$6,802
Price per share
$0.08
Number of holders
4
Value change
-$142
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 52886N117?
CUSIP 52886N117 identifies LEXXW - Lexaria Bioscience Corp. - *W EXP 01/14/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Lexaria Bioscience Corp. - *W EXP 01/14/202 (LEXXW) as of Q3 2025

As of 30 Sep 2025, Lexaria Bioscience Corp. - *W EXP 01/14/202 (LEXXW) was held by 4 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 85,026 shares. The largest 4 holders included HEIGHTS CAPITAL MANAGEMENT, INC, HEIGHTS CAPITAL MANAGEMENT, INC, UBS Group AG, and Clear Street Group Inc.. This page lists 4 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.